{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:59:19Z","timestamp":1772704759889,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31110-1","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T12:25:07Z","timestamp":1765023907000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative survival outcomes of lobectomy versus total thyroidectomy in T1 and T2 papillary thyroid cancer with more than five positive lymph nodes"],"prefix":"10.1038","volume":"16","author":[{"given":"Junhua","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingya","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqiang","family":"Dan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"31110_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"2","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Cancer statistics in China, 2015. Ca-Cancer J. Clin. 2, 115\u2013132 (2016).","journal-title":"Ca-Cancer J. Clin."},{"key":"31110_CR2","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2967\/jnumed.117.192559","volume":"8","author":"RM Tuttle","year":"2018","unstructured":"Tuttle, R. M. Controversial issues in thyroid cancer management. J. Nucl. Med. 8, 1187\u20131194 (2018).","journal-title":"J. Nucl. Med."},{"key":"31110_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"1","author":"RL Siegel","year":"2023","unstructured":"SiegelRL, MillerKD, WagleNS & Jemal, A. Cancer Statistics, 2023. Ca-Cancer J. Clin. 1, 17\u201348 (2023).","journal-title":"Ca-Cancer J. Clin."},{"key":"31110_CR4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1089\/thy.2021.0662","volume":"5","author":"UC Megwalu","year":"2022","unstructured":"Megwalu, U. C. & Moon, P. K. Thyroid cancer incidence and mortality trends in the united states: 2000\u20132018. Thyroid 5, 560\u2013570 (2022).","journal-title":"Thyroid"},{"key":"31110_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"1","author":"BR Haugen","year":"2016","unstructured":"Haugen, B. R. et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 1, 1\u2013133 (2016).","journal-title":"Thyroid"},{"key":"31110_CR6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"10387","author":"DW Chen","year":"2023","unstructured":"Chen, D. W., Lang, B., McLeod, D., Newbold, K. & Haymart, M. R. Thyroid cancer. Lancet 10387, 1531\u20131544 (2023).","journal-title":"Lancet"},{"key":"31110_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1089\/thy.2021.0557","volume":"4","author":"E Pasqual","year":"2022","unstructured":"Pasqual, E. et al. Trends in the management of localized papillary thyroid carcinoma in the united States (2000\u20132018). Thyroid 4, 397\u2013410 (2022).","journal-title":"Thyroid"},{"key":"31110_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/hed.26883","volume":"1","author":"A Sanabria","year":"2022","unstructured":"Sanabria, A. et al. Current therapeutic options for Low-Risk papillary thyroid carcinoma: Scoping evidence review. Head Neck-J Sci. Spec. 1, 226\u2013237 (2022).","journal-title":"Head Neck-J Sci. Spec."},{"key":"31110_CR9","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.6004\/jnccn.2018.0089","volume":"12","author":"RI Haddad","year":"2018","unstructured":"Haddad, R. I. et al. NCCN guidelines insights: Thyroid Carcinoma, version 2.2018. J. Natl. Compr. Canc Ne. 12, 1429\u20131440 (2018).","journal-title":"J. Natl. Compr. Canc Ne"},{"key":"31110_CR10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/thy.2017.0334","volume":"1","author":"SH Nam","year":"2018","unstructured":"Nam, S. H. et al. Nodal factors predictive of recurrence after thyroidectomy and neck dissection for papillary thyroid carcinoma. Thyroid 1, 88\u201395 (2018).","journal-title":"Thyroid"},{"key":"31110_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1089\/thy.2017.0422","volume":"3","author":"L Jianyong","year":"2018","unstructured":"Jianyong, L. et al. A nomogram based on the characteristics of metastatic lymph nodes to predict papillary thyroid carcinoma recurrence. Thyroid 3, 301\u2013310 (2018).","journal-title":"Thyroid"},{"key":"31110_CR12","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1210\/jc.2014-3882","volume":"5","author":"L Lamartina","year":"2015","unstructured":"Lamartina, L., Durante, C., Filetti, S. & Cooper, D. S. Low-Risk differentiated thyroid cancer and radioiodine remnant ablation: A systematic review of the literature. J. Clin. Endocr. Metab. 5, 1748\u20131761 (2015).","journal-title":"J. Clin. Endocr. Metab."},{"key":"31110_CR13","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1210\/jc.2014-4332","volume":"4","author":"E Ruel","year":"2015","unstructured":"Ruel, E. et al. Adjuvant radioactive iodine therapy is associated with improved survival for patients with Intermediate-Risk papillary thyroid cancer. J. Clin. Endocr. Metab. 4, 1529\u20131536 (2015).","journal-title":"J. Clin. Endocr. Metab."},{"key":"31110_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1001\/jamasurg.2022.5781","volume":"1","author":"S Xu","year":"2023","unstructured":"Xu, S. et al. Comparison of lobectomy vs total thyroidectomy for Intermediate-Risk papillary thyroid carcinoma with lymph node metastasis. Jama Surg. 1, 73\u201379 (2023).","journal-title":"Jama Surg."},{"key":"31110_CR15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/thy.2012.0307","volume":"6","author":"IJ Nixon","year":"2013","unstructured":"Nixon, I. J. et al. The results of selective use of radioactive iodine on survival and on recurrence in the management of papillary thyroid cancer, based on memorial Sloan-Kettering cancer center risk group stratification. Thyroid 6, 683\u2013694 (2013).","journal-title":"Thyroid"},{"key":"31110_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1089\/thy.2021.0356","volume":"1","author":"D Matsuura","year":"2022","unstructured":"Matsuura, D. et al. Surgical management of Low-\/Intermediate-Risk node negative thyroid cancer: A Single-Institution study using propensity matching analysis to compare thyroid lobectomy and total thyroidectomy. Thyroid 1, 28\u201336 (2022).","journal-title":"Thyroid"},{"key":"31110_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1097\/SLA.0000000000000925","volume":"4","author":"MA Adam","year":"2014","unstructured":"Adam, M. A. et al. Extent of surgery for papillary thyroid cancer is not associated with survival: An analysis of 61,775 patients. Ann. Surg. 4, 601\u2013605 (2014).","journal-title":"Ann. Surg."},{"key":"31110_CR18","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/SLA.0b013e31814697d9","volume":"3","author":"KY Bilimoria","year":"2007","unstructured":"Bilimoria, K. Y. et al. Extent of surgery affects survival for papillary thyroid cancer. Ann. Surg. 3, 375\u2013381 (2007).","journal-title":"Ann. Surg."},{"key":"31110_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jamcollsurg.2019.09.021","volume":"1","author":"P Suman","year":"2020","unstructured":"Suman, P. et al. Thyroid lobectomy for T1B-T2 papillary thyroid cancer with High-Risk features. J. Am. Coll. Surg. 1, 136\u2013144 (2020).","journal-title":"J. Am. Coll. Surg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31110-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31110-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:01:55Z","timestamp":1772701315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31110-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31110"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31110-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"4 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this Article was revised: In the original version of this Article the Tables were ordered incorrectly. The original article has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The protocol for this study was approved by the Ethics Committee of Chengdu Fifth People\u2019s Hospital (The Second Clincal Medical College, Affiliated Fifth People\u2019s Hospital of Chengdu University of Traditional Chinese Medicine).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"1445"}}